Levodopa + Carbidopa bulk supplier for pharma manufacturers

Levodopa + Carbidopa Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: IR: 100 mg/25 mg , 250 mg/25 mg; ER: 200 mg/50 mg

Reference Brands: Sinemet®(US & EU); Rytary®, Parcopa®, Duodopa®

Levodopa-Carbidopa treats Parkinson’s disease, available in 100/25 mg, 250/25 mg, and 200/50 mg tablets. Brands include Sinemet®, Rytary®, and Duodopa®. Pharma B2B platforms enable global sourcing from GMP-certified manufacturers, ensuring regulatory-compliant, high-quality bulk supply for hospitals, pharmacies, and neurology care providers

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Levodopa + Carbidopa? List it or send an offer →

Product Description: Levodopa-Carbidopa is a first-line treatment for Parkinson’s disease, available in various oral formulations including immediate-release, extended-release, and orally disintegrating tablets. It is also supplied as Duodopa® intestinal gel for advanced stages. Common strengths include 100/25 mg, 250/25 mg, and 200/50 mg. Leading brands include Sinemet®, Rytary®, and Duodopa® in both the US and EU markets. Levodopa restores dopamine, while Carbidopa enhances its CNS availability and reduces side effects. Pharma B2B marketplaces connect global buyers with GMP-compliant manufacturers of Levodopa-Carbidopa, offering regulatory-compliant, bulk supply solutions for hospitals, distributors, and neurology-focused pharma procurement.

Levodopa + Carbidopa — third party manufacturing & bulk supply

Levodopa + Carbidopa is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Levodopa + Carbidopa is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Levodopa + Carbidopa listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Levodopa + Carbidopa →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Levodopa + Carbidopa is listed as Tablets in IR: 100 mg/25 mg , 250 mg/25 mg; ER: 200 mg/50 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Levodopa + Carbidopa is referenced against Sinemet®(US & EU); Rytary®, Parcopa®, Duodopa®. Reference brands are shown for identification only and remain the property of their respective trademark owners.